To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC) (PIONEER)

AstraZeneca

Status: Completed

Conditions: Non Small Cell Lung Cancer

Treatments: Procedure: Testing for mutation status

Study type: Interventional

Funder types: Industry

Identifiers

NCT01185314

D7913L00086

Details and patient eligibility

About

The purpose of this study is to study the changes in protein in lung cells of Asian patients with advanced non small cell lung cancer.

Full description

A molecular epidemiology study in Asian patients with advanced NSCLC of adeno histology to assess EGFR mutation status.

Enrollment: 1,270 estimated patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Histological or cytologically confirmed advanced Non small cell lung cancer of adeno histology NSCLC treatment naive Availability of cancer tissue or cytology sample

Exclusion criteria

• Involvement in the planning and/or conduct of the study Previous enrollment in the present study

Trial design

Primary purpose: Screening

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

1,270 participants in 1 patient group

1

Other group

Description:

EGFR mutation testing

Treatment:

Procedure: Testing for mutation status